Skip to content

Inogen INGN EV / sales

EV / sales at other companies

ResMed logo
ResMedRMD
5.8×-0.7×
AdaptHealth logo
AdaptHealthAHCO
1.1×0.0×
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
1.3×0.0×
Pulmonx Corporation logo
Pulmonx CorporationLUNG
0.6×-2.4×
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
1.6×+0.6×
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
4.6×-0.2×

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Calculated from Inogen’s reported figures.

Based on the most recent quarter.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's EV / sales?
Inogen (INGN) reported EV / sales of 0.3× in Q1 2026.
How has Inogen's EV / sales changed year-over-year?
Inogen's EV / sales decreased by 3.2% year-over-year, from 0.3× to 0.3×.
What is the long-term trend for Inogen's EV / sales?
Over 5 years (2020 to 2025), Inogen's EV / sales has grown at a -36.3% compound annual growth rate (CAGR), from 2.6× to 0.3×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.